Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Philadelphia College of Osteopathic Medicine

Conference

2022

3-chymotrypsin like protease (3CLpro)

Articles 1 - 1 of 1

Full-Text Articles in Medicine and Health Sciences

Identification Of Phytochemicals That Inhibit The Enzymatic Activity Of Sars-Cov-2 3-Chymotrypsin Like Protease (3clpro) In Vitro., Avini Sharma, Anasha Kawall, Devin Lewis, Krishna Chavada, Shashidharamurthy Taval, Vicky Mody, Srujana Rayalam May 2022

Identification Of Phytochemicals That Inhibit The Enzymatic Activity Of Sars-Cov-2 3-Chymotrypsin Like Protease (3clpro) In Vitro., Avini Sharma, Anasha Kawall, Devin Lewis, Krishna Chavada, Shashidharamurthy Taval, Vicky Mody, Srujana Rayalam

Research Day

SARS-CoV-2, which emerged in Wuhan, China in December of 2019, is classified as a global pandemic. Several studies suggest that phytochemicals exhibit potent anti-viral effects and in this study, we have investigated the use of phytochemicals as potential anti-SARS-CoV-2 agents. Previous studies indicated the importance of viral proteases in the replication of SARS-CoV-2. Among these proteases, papain-like protease and 3-chymotrypsin-like protease are involved in the synthesis of non-structural proteins responsible for the assembly of the replication-transcription complex. Phytochemicals such as rutin, myricetin, and kaempferol, were reported as potential inhibitors of 3CLpro activity in silico. However, recently we have established that …